Legal Representation
Attorney
Michael H. Jacobs
USPTO Deadlines
Application History
32 eventsDate | Code | Type | Description |
---|---|---|---|
Jun 18, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Jun 18, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Mar 21, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Mar 21, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Mar 21, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Mar 19, 2025 | GNRT | O | NON-FINAL ACTION E-MAILED |
Mar 19, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Mar 19, 2025 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
Mar 18, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Feb 19, 2025 | DPCC | D | DIVISIONAL PROCESSING COMPLETE |
Feb 11, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Nov 27, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Nov 27, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED |
Nov 27, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED |
Nov 27, 2024 | IUAF | S | USE AMENDMENT FILED |
Jun 4, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Apr 25, 2024 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
Apr 5, 2024 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED |
Apr 2, 2024 | APET | A | ASSIGNED TO PETITION STAFF |
Feb 28, 2024 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED |
Nov 13, 2023 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
Oct 17, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Oct 17, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
Sep 27, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Sep 8, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Sep 7, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Sep 7, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
Sep 7, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Sep 7, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Sep 5, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
Feb 27, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Feb 10, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Providing medical and scientific research information in the field of pharmaceutical research for the treatment of neurological disorders and central nervous system disorders
First Use Anywhere:
Feb 6, 2023
First Use in Commerce:
Feb 6, 2023
Class 044
Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals for the treatment of neurological disorders and central nervous system disorders; providing information in the field of treatment of neurological disorders and central nervous system disorders; consulting services in the field of pharmaceuticals for the treatment of neurological disorders and central nervous system disorders
First Use Anywhere:
Feb 6, 2023
First Use in Commerce:
Feb 6, 2023
Classification
International Classes
042
044